Yersinia enterocolitica in Crohn's disease

Front Cell Infect Microbiol. 2023 Mar 8:13:1129996. doi: 10.3389/fcimb.2023.1129996. eCollection 2023.

Abstract

Increasing attention is being paid to the unique roles gut microbes play in both physiological and pathological processes. Crohn's disease (CD) is a chronic, relapsing, inflammatory disease of the gastrointestinal tract with unknown etiology. Currently, gastrointestinal infection has been proposed as one initiating factor of CD. Yersinia enterocolitica, a zoonotic pathogen that exists widely in nature, is one of the most common bacteria causing acute infectious gastroenteritis, which displays clinical manifestations similar to CD. However, the specific role of Y. enterocolitica in CD is controversial. In this Review, we discuss the current knowledge on how Y. enterocolitica and derived microbial compounds may link to the pathogenesis of CD. We highlight examples of Y. enterocolitica-targeted interventions in the diagnosis and treatment of CD, and provide perspectives for future basic and translational investigations on this topic.

Keywords: Crohn’s disease; Yersinia enterocolitica; gut microbiota; immune system; inflammation bowel disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crohn Disease* / microbiology
  • Gastrointestinal Diseases*
  • Humans
  • Yersinia Infections* / diagnosis
  • Yersinia Infections* / microbiology
  • Yersinia enterocolitica*

Grants and funding

This work was supported by the National Natural Science Foundation of China (Grant No.81800479, No.82170568) and Shanghai Pujiang Program (No.22PJD015).